Mindray Ultrasound Systems at RSNA - Analyst Blog

A generic image of a digital screen
Credit: Shutterstock photo

Leading Chinese medical devices maker Mindray Medical International Limited ( MR ) will unveil a new ultrasound system at the ongoing Radiology Society of North America ("RSNA") annual meet in Chicago. The new system dubbed DC-T6 is a high performance imaging platform with a user-friendly, compact mobile design.

The affordable DC-T6 sports a high-resolution, 15-inch TFT monitor and a swivel and height-adjustable control panel. It also features iPower, an embedded battery, which offers up to two hours of interruptible scanning when power is not available. Among other special features, DC-T6 offers a real-time 4D and panoramic imaging.

Besides DC-T6, Mindray will also showcase significant enhancements for its M7 and DC-7 ultrasound platforms at the RSNA meet. The company will unveil new upgrades to the DC-7 system including an iPage 3D volume data series, a 3D/4D spatial-cutting tool and a new transducer.

For M7, the enhancements include iNeedle, a new needle detection technology for interventional and vascular access procedures. Moreover, Mindray will feature the iZoom software which enables more accurate and clear visualization of patient anatomy from a distance.

The high-end segment of the ultrasound business is growing at a brisk pace as more and more healthcare providers acquire sophisticated capability but in compact and portable form.

Mindray is a bellwether in the Chinese MedTech industry with a solid international presence. The company maintains a decent product pipeline and brings out several new products every year.

Mindray remains committed to providing clinicians with the latest technology that enhances patient care. The company's state-of-the-art ultrasound systems are enjoying healthy traction in North America.

Besides China, Mindray operates in North America, Europe and other Asian countries. The company competes with global devices manufacturers such as General Electric ( GE ), Philips ( PHG ) and Siemens ( SI ). We currently have a long-term Neutral rating on Mindray. The stock currently retains a Zacks #3 Rank, which translates into a short-term Hold recommendation.

GENL ELECTRIC ( GE ): Free Stock Analysis Report

MINDRAY MEDICAL ( MR ): Free Stock Analysis Report

KONINKLIJKE PHL ( PHG ): Free Stock Analysis Report

SIEMENS AG-ADR ( SI ): Free Stock Analysis Report

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Other Topics


Latest Markets Videos


    Zacks is the leading investment research firm focusing on stock research, analysis and recommendations. In 1978, our founder discovered the power of earnings estimate revisions to enable profitable investment decisions. Today, that discovery is still the heart of the Zacks Rank. A wealth of resources for individual investors is available at

    Learn More